The Theranos and Point-Of-Care Testing phenomena, coupled to fears that European governments will keep bearing down on lab tariffs, explains why none of the big groups managed to sell in 2014.
Euromedic, the largest European imaging service provider and which is also active in labs and radiotherapy, is to rebrand as Affidea. We will carry an interview on the move with CEO Dimitris Moulavasilis tomorrow.
Egyptian lab group IDH (Integrated Diagnostics Holdings) is using Egypt’s more settled political situation to cash in on mega-profits. The group expects a market capitalisation of $600m at IPO and could float up to 45% of the share capital. Before tax profits came to $21m, a margin of 25%, in the financial year ending 30 Sep 2014, on sales of $87m, up 27.5%. EBITDA margin stands at 42%.
You’d be forgiven for thinking that a cut of more than half in the price of oil, the chief export of the Gulf, would lead to a risk to healthcare provision.
Healthcare Nova looks at the potential for residential care in China, names all the major foreign players active in the sector and talks to operators running homes today in China. How best can companies enter the market? And how large is it? What are the price points charged today for high-end care? By Helen Burgraff
Despite crude more than halving in price, healthcare services are set to grow fast in the Arab oil states (the Gulf Cooperation Council). That reflects the introduction of mandatory health insurance, the rise of chronic disease and a growing population. We investigate.
Narayana, the revolutionary low cost Indian hospital chain, has had had an equity injection of some $47.5m from CDC, the UK development bank. Founder and majority shareholder Dr Devi Shetty, the Henry Ford of heart surgery, wants to grow from 5,000 beds to 30,000. We talk to David Easton, head of healthcare at CDC, about the deal.
A new player in the French complementary health insurer market with nearly a fifth of the market and covering 11m customers is to be created by the merger of two mutual insurers. The move heralds the creation of a chain of 348 outpatient health centres. Healthcare Europa talks to the directeur-generale of one of the merging groups.
Bulgarian hospital chain City Clinic is set to build three new facilities across the country in a BGN200m (€102m) investment. We spoke to Entrea Capital, the investment advisory group working with City Clinic, about the group’s expansion.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
